12 August 2019

ICH is announcing a public meeting entitled “ICH Global Meeting on E8(R1) Guideline on General Considerations for Clinical Trials.” The purpose of the public meeting is to provide information and solicit input from a broad range of non-ICH Member/Observer stakeholders on the draft revised E8(R1) Guideline “General Considerations for Clinical Trials.” The meeting will take place on October 31st, 2019, 8:30 – 18:00, at the headquarters of FDA, United States in Silver Spring, MD, USA. Participants can register to attend in-person or via webcast, pending available space...

See the complete press release